Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Prostate Cancer

  Free Subscription


Articles published in Oncol Rep

Retrieve available abstracts of 53 articles:
HTML format
Text format



Single Articles


    March 2017
  1. ZHAO Y, Yan M, Yun Y, Zhang J, et al
    MicroRNA-455-3p functions as a tumor suppressor by targeting eIF4E in prostate cancer.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5502.
    PubMed     Text format     Abstract available


  2. BAI Y, Xiao Y, Dai Y, Chen X, et al
    Stanniocalcin 1 promotes cell proliferation via cyclin E1/cyclindependent kinase 2 in human prostate carcinoma.
    Oncol Rep. 2017 Mar 13. doi: 10.3892/or.2017.5501.
    PubMed     Text format     Abstract available


  3. TAO T, Chen M, Jiang R, Guan H, et al
    Involvement of EZH2 in aerobic glycolysis of prostate cancer through miR-181b/HK2 axis.
    Oncol Rep. 2017;37:1430-1436.
    PubMed     Text format     Abstract available


    February 2017
  4. YU H, Sun SQ, Gu XB, Wang W, et al
    Atorvastatin prolongs the lifespan of radiationinduced reactive oxygen species in PC-3 prostate cancer cells to enhance the cell killing effect.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5447.
    PubMed     Text format     Abstract available


  5. KONG Q, Chen XS, Tian T, Xia XY, et al
    MicroRNA-194 suppresses prostate cancer migration and invasion by downregulating human nuclear distribution protein.
    Oncol Rep. 2017;37:803-812.
    PubMed     Text format     Abstract available


    January 2017
  6. LIU Y, Qin Z, Yang K, Liu R, et al
    Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/beta-catenin signaling.
    Oncol Rep. 2017 Jan 17. doi: 10.3892/or.2017.5378.
    PubMed     Text format     Abstract available


  7. HE Y, Huang H, Farischon C, Li D, et al
    Combined effects of atorvastatin and aspirin on growth and apoptosis in human prostate cancer cells.
    Oncol Rep. 2017 Jan 4. doi: 10.3892/or.2017.5353.
    PubMed     Text format     Abstract available


  8. LIU B, Gu X, Huang T, Luan Y, et al
    Identification of TMPRSS2-ERG mechanisms in prostate cancer invasiveness: Involvement of MMP-9 and plexin B1.
    Oncol Rep. 2017;37:201-208.
    PubMed     Text format     Abstract available


  9. SUN W, Guo L, Shao G, Liu X, et al
    Suppression of LASP-1 attenuates the carcinogenesis of prostatic cancer cell lines: Key role of the NF-kappaB pathway.
    Oncol Rep. 2017;37:341-347.
    PubMed     Text format     Abstract available


    December 2016
  10. YIN H, Sheng Z, Zhang X, Du Y, et al
    Overexpression of SOX18 promotes prostate cancer progression via the regulation of TCF1, c-Myc, cyclin D1 and MMP-7.
    Oncol Rep. 2016 Dec 2. doi: 10.3892/or.2016.5288.
    PubMed     Text format     Abstract available


    November 2016
  11. LI S, Wang C, Yu X, Wu H, et al
    miR-3619-5p inhibits prostate cancer cell growth by activating CDKN1A expression.
    Oncol Rep. 2016 Nov 16. doi: 10.3892/or.2016.5250.
    PubMed     Text format     Abstract available


  12. JANG IS, Park JW, Jo EB, Cho CK, et al
    Growth inhibitory and apoptosis-inducing effects of allergen-free Rhus verniciflua Stokes extract on A549 human lung cancer cells.
    Oncol Rep. 2016;36:3037-3043.
    PubMed     Text format     Abstract available


  13. OHNISHI Y, Yasui H, Kakudo K, Nozaki M, et al
    Lapatinib-resistant cancer cells possessing epithelial cancer stem cell properties develop sensitivity during sphere formation by activation of the ErbB/AKT/cyclin D2 pathway.
    Oncol Rep. 2016;36:3058-3064.
    PubMed     Text format     Abstract available


    October 2016
  14. LAI X, Guo Y, Guo Z, Liu R, et al
    Downregulation of microRNA574 in cancer stem cells causes recurrence of prostate cancer via targeting REL.
    Oncol Rep. 2016 Oct 24. doi: 10.3892/or.2016.5196.
    PubMed     Text format     Abstract available


  15. XU L, Wang Z, He SY, Zhang SF, et al
    Bax-interacting factor-1 inhibits cell proliferation and promotes apoptosis in prostate cancer cells.
    Oncol Rep. 2016 Oct 14. doi: 10.3892/or.2016.5172.
    PubMed     Text format     Abstract available


  16. ZHANG W, Liu J, Qiu J, Fu X, et al
    MicroRNA-382 inhibits prostate cancer cell proliferation and metastasis through targeting COUP-TFII.
    Oncol Rep. 2016 Oct 3. doi: 10.3892/or.2016.5141.
    PubMed     Text format     Abstract available


    August 2016
  17. CHEN Y, Zhao J, Luo Y, Wang Y, et al
    Downregulated expression of miRNA-149 promotes apoptosis in side population cells sorted from the TSU prostate cancer cell line.
    Oncol Rep. 2016 Aug 25. doi: 10.3892/or.2016.5047.
    PubMed     Text format     Abstract available


  18. ZHANG X, Wang L, Wang Y, Shi S, et al
    Inhibition of FOXQ1 induces apoptosis and suppresses proliferation in prostate cancer cells by controlling BCL11A/MDM2 expression.
    Oncol Rep. 2016 Aug 11. doi: 10.3892/or.2016.5018.
    PubMed     Text format     Abstract available


  19. FIALOVA B, Luzna P, Gursky J, Langova K, et al
    Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.
    Oncol Rep. 2016 Aug 3. doi: 10.3892/or.2016.5000.
    PubMed     Text format     Abstract available


  20. HUANG S, Tang Y, Peng X, Cai X, et al
    Acidic extracellular pH promotes prostate cancer bone metastasis by enhancing PC-3 stem cell characteristics, cell invasiveness and VEGF-induced vasculogenesis of BM-EPCs.
    Oncol Rep. 2016 Aug 2. doi: 10.3892/or.2016.4997.
    PubMed     Text format     Abstract available


    July 2016
  21. TIAN H, Zhou Y, Yang G, Geng Y, et al
    Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
    Oncol Rep. 2016 Jul 15. doi: 10.3892/or.2016.4942.
    PubMed     Text format     Abstract available


  22. PING H, Yang F, Wang M, Niu Y, et al
    IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
    Oncol Rep. 2016 Jul 7. doi: 10.3892/or.2016.4915.
    PubMed     Text format     Abstract available


    June 2016
  23. WANG D, Zhu L, Liao M, Zeng T, et al
    MYO6 knockdown inhibits the growth and induces the apoptosis of prostate cancer cells by decreasing the phosphorylation of ERK1/2 and PRAS40.
    Oncol Rep. 2016 Jun 29. doi: 10.3892/or.2016.4910.
    PubMed     Text format     Abstract available


  24. KIM TD, Shin S, Janknecht R
    ETS transcription factor ERG cooperates with histone demethylase KDM4A.
    Oncol Rep. 2016;35:3679-88.
    PubMed     Text format     Abstract available


    May 2016
  25. GRAVINA GL, Marampon F, Sanita P, Mancini A, et al
    Increased expression and activity of p75NTR are crucial events in azacitidine-induced cell death in prostate cancer.
    Oncol Rep. 2016 May 23. doi: 10.3892/or.2016.4832.
    PubMed     Text format     Abstract available


  26. YANG Y, Lu Y, Wang L, Mizokami A, et al
    Skp2 is associated with paclitaxel resistance in prostate cancer cells.
    Oncol Rep. 2016 May 13. doi: 10.3892/or.2016.4809.
    PubMed     Text format     Abstract available


  27. XU S, Yi XM, Tang CP, Ge JP, et al
    Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4791.
    PubMed     Text format     Abstract available


  28. ZHANG X, Tao T, Liu C, Guan H, et al
    Downregulation of miR-195 promotes prostate cancer progression by targeting HMGA1.
    Oncol Rep. 2016 May 9. doi: 10.3892/or.2016.4797.
    PubMed     Text format     Abstract available


    April 2016
  29. LI M, Wang YX, Luo Y, Zhao J, et al
    Hypoxia inducible factor-1alpha-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.
    Oncol Rep. 2016 Apr 25. doi: 10.3892/or.2016.4766.
    PubMed     Text format     Abstract available


    March 2016
  30. LI F, Gu C, Tian F, Jia Z, et al
    miR-218 impedes IL-6-induced prostate cancer cell proliferation and invasion via suppression of LGR4 expression.
    Oncol Rep. 2016 Mar 8. doi: 10.3892/or.2016.4663.
    PubMed     Text format     Abstract available


  31. KOU B, Liu W, He W, Zhang Y, et al
    Tetrandrine suppresses metastatic phenotype of prostate cancer cells by regulating Akt/mTOR/MMP-9 signaling pathway.
    Oncol Rep. 2016 Mar 3. doi: 10.3892/or.2016.4649.
    PubMed     Text format     Abstract available


    February 2016
  32. WANG X, Niu Z, Jia Y, Cui M, et al
    Ubenimex inhibits cell proliferation, migration and invasion by inhibiting the expression of APN and inducing autophagic cell death in prostate cancer cells.
    Oncol Rep. 2016 Feb 3. doi: 10.3892/or.2016.4611.
    PubMed     Text format     Abstract available


  33. TANG J, Xiao L, Cui R, Li D, et al
    CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-alpha/EGFR pathway in hypoxic androgenindependent prostate cancer cells.
    Oncol Rep. 2016;35:1153-1162.
    PubMed     Text format     Abstract available


  34. HUANG K, Tang Y, He L, Dai Y, et al
    MicroRNA-340 inhibits prostate cancer cell proliferation and metastasis by targeting the MDM2-p53 pathway.
    Oncol Rep. 2016;35:887-895.
    PubMed     Text format     Abstract available


    January 2016
  35. YANG K, Shen J, Chen SW, Qin J, et al
    Upregulation of PAWR by small activating RNAs induces cell apoptosis in human prostate cancer cells.
    Oncol Rep. 2016 Jan 21. doi: 10.3892/or.2016.4582.
    PubMed     Text format     Abstract available


  36. KIM YR, Kang TW, To PK, Xuan Nguyen NT, et al
    HOXB13-mediated suppression of p21WAF1/CIP1 regulates JNK/c-Jun signaling in prostate cancer cells.
    Oncol Rep. 2016 Jan 15. doi: 10.3892/or.2016.4563.
    PubMed     Text format     Abstract available


    December 2015
  37. KANG M, Ho JN, Kook HR, Lee S, et al
    Theracurmin(R) efficiently inhibits the growth of human prostate and bladder cancer cells via induction of apoptotic cell death and cell cycle arrest.
    Oncol Rep. 2015 Dec 29. doi: 10.3892/or.2015.4537.
    PubMed     Text format     Abstract available


  38. YANG F, Jiang X, Song L, Wang H, et al
    Quercetin inhibits angiogenesis through thrombospondin-1 upregulation to antagonize human prostate cancer PC-3 cell growth in vitro and in vivo.
    Oncol Rep. 2015 Dec 9. doi: 10.3892/or.2015.4481.
    PubMed     Text format     Abstract available


    November 2015
  39. WANG L, Dong J, Wei M, Wen W, et al
    Selective and augmented beta-glucuronidase expression combined with DOX-GA3 application elicits the potent suppression of prostate cancer.
    Oncol Rep. 2015 Nov 26. doi: 10.3892/or.2015.4454.
    PubMed     Text format     Abstract available


    October 2015
  40. LI X, Li T, Chen D, Zhang P, et al
    Overexpression of lysine-specific demethylase 1 promotes androgen-independent transition of human prostate cancer LNCaP cells through activation of the AR signaling pathway and suppression of the p53 signaling pathway.
    Oncol Rep. 2015 Oct 30. doi: 10.3892/or.2015.4362.
    PubMed     Text format     Abstract available


  41. LI Q, Lai Y, Wang C, Xu G, et al
    Matrine inhibits the proliferation, invasion and migration of castration-resistant prostate cancer cells through regulation of the NF-kappaB signaling pathway.
    Oncol Rep. 2015 Oct 21. doi: 10.3892/or.2015.4341.
    PubMed     Text format     Abstract available


  42. LIAO H, Xiao Y, Hu Y, Xiao Y, et al
    Methylation-induced silencing of miR-34a enhances chemoresistance by directly upregulating ATG4B-induced autophagy through AMPK/mTOR pathway in prostate cancer.
    Oncol Rep. 2015 Oct 16. doi: 10.3892/or.2015.4331.
    PubMed     Text format     Abstract available


  43. CIFUENTES FF, Valenzuela RH, Contreras HR, Castellon EA, et al
    Surgical cytoreduction of the primary tumor reduces metastatic progression in a mouse model of prostate cancer.
    Oncol Rep. 2015 Oct 1. doi: 10.3892/or.2015.4319.
    PubMed     Text format     Abstract available


    September 2015
  44. ZHANG Y, Liu K, Zhang Y, Qi J, et al
    ABL-N may induce apoptosis of human prostate cancer cells through suppression of KLF5, ICAM-1 and Stat5b, and upregulation of Bax/Bcl-2 ratio: An in vitro and in vivo study.
    Oncol Rep. 2015 Sep 18. doi: 10.3892/or.2015.4293.
    PubMed     Text format     Abstract available


  45. ZHENG K, Dou Y, He L, Li H, et al
    Improved sensitivity and specificity for prostate cancer diagnosis based on the urine PCA3/PSA ratio acquired by sequencespecific RNA capture.
    Oncol Rep. 2015 Sep 9. doi: 10.3892/or.2015.4266.
    PubMed     Text format     Abstract available


    August 2015
  46. YAN J, Ma C, Cheng J, Li Z, et al
    HAX-1 inhibits apoptosis in prostate cancer through the suppression of caspase-9 activation.
    Oncol Rep. 2015 Aug 13. doi: 10.3892/or.2015.4202.
    PubMed     Text format     Abstract available


  47. DU Y, Long Q, Shi Y, Liu X, et al
    Insulin-like growth factor binding protein-3 mediates interleukin-24-induced apoptosis through inhibition of the mTOR pathway in prostate cancer.
    Oncol Rep. 2015 Aug 13. doi: 10.3892/or.2015.4201.
    PubMed     Text format     Abstract available


    July 2015
  48. GANG X, Wang Y, Wang Y, Zhao Y, et al
    Suppression of casein kinase 2 sensitizes tumor cells to antitumor TRAIL therapy by regulating the phosphorylation and localization of p65 in prostate cancer.
    Oncol Rep. 2015 Jul 13. doi: 10.3892/or.2015.4123.
    PubMed     Text format     Abstract available


  49. PENG X, Zhou Y, Tian H, Yang G, et al
    Sulforaphane inhibits invasion by phosphorylating ERK1/2 to regulate E-cadherin and CD44v6 in human prostate cancer DU145 cells.
    Oncol Rep. 2015 Jul 1. doi: 10.3892/or.2015.4098.
    PubMed     Text format     Abstract available


    June 2015
  50. WANG H, Liu G, Shen D, Ye H, et al
    HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.
    Oncol Rep. 2015 Jun 26. doi: 10.3892/or.2015.4085.
    PubMed     Text format     Abstract available


  51. ZHENG L, Chen J, Ma Z, Liu W, et al
    Capsaicin causes inactivation and degradation of the androgen receptor by inducing the restoration of miR-449a in prostate cancer.
    Oncol Rep. 2015 Jun 11. doi: 10.3892/or.2015.4055.
    PubMed     Text format     Abstract available


    May 2015
  52. HOTTA K, Sho M, Fujimoto K, Shimada K, et al
    Clinical significance and therapeutic potential of prostate cancer antigen-1/ALKBH3 in human renal cell carcinoma.
    Oncol Rep. 2015 May 29. doi: 10.3892/or.2015.4017.
    PubMed     Text format     Abstract available


    March 2015
  53. GAO W, Su X, Dong X, Chen Y, et al
    Cycloartan-24-ene-1alpha,2alpha,3beta-triol, a cycloartane-type triterpenoid from the resinous exudates of Commiphora myrrha, induces apoptosis in human prostatic cancer PC-3 cells.
    Oncol Rep. 2015;33:1107-14.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: